GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NanoEcho AB (publ) (OSTO:NANECH) » Definitions » EBIT per Share

NanoEcho AB (publ) (OSTO:NANECH) EBIT per Share : kr-0.06 (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is NanoEcho AB (publ) EBIT per Share?

NanoEcho AB (publ)'s EBIT per Share for the three months ended in Dec. 2024 was kr-0.02. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was kr-0.06.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for NanoEcho AB (publ)'s EBIT per Share or its related term are showing as below:

OSTO:NANECH's 3-Year EBIT Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 8
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

NanoEcho AB (publ)'s EBIT for the three months ended in Dec. 2024 was kr-3.51 Mil.


NanoEcho AB (publ) EBIT per Share Historical Data

The historical data trend for NanoEcho AB (publ)'s EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoEcho AB (publ) EBIT per Share Chart

NanoEcho AB (publ) Annual Data
Trend Dec22 Dec23 Dec24
EBIT per Share
-0.12 -0.10 -0.13

NanoEcho AB (publ) Quarterly Data
Dec22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24
EBIT per Share Get a 7-Day Free Trial -0.02 -0.03 -0.03 -0.02 -0.02

NanoEcho AB (publ) EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

NanoEcho AB (publ)'s EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

EBIT per Share(A: Dec. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=-15.142/117.916
=-0.13

NanoEcho AB (publ)'s EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

EBIT per Share(Q: Dec. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=-3.509/200.544
=-0.02

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NanoEcho AB (publ)  (OSTO:NANECH) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


NanoEcho AB (publ) EBIT per Share Related Terms

Thank you for viewing the detailed overview of NanoEcho AB (publ)'s EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


NanoEcho AB (publ) Business Description

Traded in Other Exchanges
N/A
Address
Scheelevagen 19, Lund, SWE, 223 63
NanoEcho AB (publ) is a Swedish medical technology company. The company is developing a new diagnostic method to track rectal cancer's effect on nearby lymph nodes for the generation of health economic gains. The company's imaging technology is based on a new medical method where nanotechnology is combined with modern ultrasound technology to improve diagnosis methods.

NanoEcho AB (publ) Headlines

No Headlines